Aerpio Pharmaceuticals, Inc. Contracts & Agreements

Form of Registration Rights Agreement, by and among Aadi Bioscience, Inc. and the purchasers thereto (Filed With SEC on December 20, 2024)

Subscription Agreement, dated December 19, 2024, and each purchaser identified on Exhibit A thereto (Filed With SEC on December 20, 2024)

Form of Voting and Support Agreement, dated as of December 19, 2024, among KAKEN INVESTMENTS INC., Aadi Bioscience, Inc. and the stockholder of Aadi Bioscience, Inc. party thereto (Filed With SEC on December 20, 2024)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on December 20, 2024)

Stock Purchase Agreement, dated December 19, 2024, among Aadi Bioscience, Inc., KAKEN INVESTMENTS INC., KAKEN PHARMACEUTICAL CO., LTD., and Aadi Subsidiary, Inc (Filed With SEC on December 20, 2024)

Amendment No.3 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, effective as of July 31, 2024, by and between Aadi Bioscience, Inc. and... (Filed With SEC on November 6, 2024)

Transition Agreement and Release by and between Neil Desai and Aadi Bioscience, Inc., dated October 16, 2024 (Filed With SEC on November 6, 2024)

Transition Agreement and Release by and between Loretta Itri and Aadi Bioscience, Inc., dated September 16, 2024 (Filed With SEC on November 6, 2024)

Form of Retention Bonus Letter (Filed With SEC on September 19, 2024)

Executive Employment Agreement, dated August 15, 2022, by and between the Company and Bryan E. Ball (Filed With SEC on August 7, 2024)

Amended and Restated Outside Director Compensation Plan (Filed With SEC on August 7, 2024)

Amendment No.2 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated April 1, 2024, by and between Aadi Bioscience, Inc. and Fresenius... (Filed With SEC on May 8, 2024)

Description of Registrant's Capital Stock (Filed With SEC on March 13, 2024)

Form of Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan Stock Option Agreement (Filed With SEC on October 2, 2023)

Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan (Filed With SEC on October 2, 2023)

Executive Employment Agreement, dated September 29, 2023, by and between David J. Lennon and Aadi Bioscience, Inc (Filed With SEC on October 2, 2023)

Form of Restricted Stock Unit Award Agreement under the Aadi Bioscience, Inc. 2021 Equity Incentive Plan (Filed With SEC on October 2, 2023)

Form of Registration Rights Agreement, dated September 22, 2022, by and among the Company and the Purchasers (Filed With SEC on September 22, 2022)

Form of Securities Purchase Agreement, dated September 22, 2022, by and among the Company and the Purchasers (Filed With SEC on September 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on September 22, 2022)

Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated as of January 13, 2022, by and between the Company and Fresenius Kabi, LLC (Filed With SEC on May 12, 2022)

Description of common stock (Filed With SEC on March 17, 2022)

Executive Employment Agreement, dated October 28, 2021, by and between Aadi Bioscience, Inc. and Scott Giacobello (Filed With SEC on March 17, 2022)

Sales Agreement dated as of March 17, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 17, 2022)

Amended and Restated License Agreement by and between Abraxis BioScience, LLC and Aadi Bioscience, Inc. dated November 15, 2019 (Filed With SEC on November 10, 2021)

Amendment No. 1 to the Amended and Restated License Agreement between Abraxis BioScience, LLC and Aadi Bioscience, Inc (Filed With SEC on November 10, 2021)

First Amendment to Office Lease dated August 30, 2021 by and between BRE Sunset Coast, LLC and Aadi Bioscience, Inc (Filed With SEC on November 10, 2021)

Employment Agreement dated October 19, 2021, by and between Loretta Itri and Aadi Bioscience, Inc (Filed With SEC on November 10, 2021)

License Agreement by and between Aadi Bioscience, Inc. and EOC Pharma (Hong Kong) Limited dated December 8, 2020 (Filed With SEC on November 10, 2021)

Employment Agreement dated September 14, 2021, by and between Brendan Delaney and the Company (Filed With SEC on September 20, 2021)

Consulting Agreement, dated July 20, 2021, by and between Aadi Bioscience, Inc. and Danforth Advisors, LLC (Filed With SEC on August 27, 2021)

Aadi Bioscience, Inc. 2014 Equity Incentive Plan (Filed With SEC on August 27, 2021)

Amended and Restated Employment Agreement, dated August 26, 2021, by and between Aadi Bioscience, Inc. and Neil Desai, Ph.D (Filed With SEC on August 27, 2021)

Registration Rights Agreement, dated August 26, 2021, by and between Aadi Bioscience, Inc. (formerly known as Aerpio Pharmaceuticals, Inc.) and certain purchasers listed therein (Filed With SEC on August 27, 2021)

Contingent Value Rights Agreement dated August 26, 2021, by and between Aerpio Pharmaceuticals, Inc., Cheryl Cohen, as Holder Representative, and American Stock Transfer & Trust... (Filed With SEC on August 27, 2021)

Aadi Bioscience, Inc. 2021 Equity Incentive Plan (Filed With SEC on August 27, 2021)

Form of Stock Option Agreement under the Aadi Bioscience, Inc. 2021 Equity Incentive Plan (Filed With SEC on August 27, 2021)

Form of Indemnification Agreement between Aadi Bioscience, Inc. and each of its directors and executive officers (Filed With SEC on August 27, 2021)

Form of Stock Option Agreement under the Aadi Bioscience, Inc. 2014 Equity Incentive Plan (Filed With SEC on August 27, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on August 27, 2021)

Asset Purchase Agreement dated August 17, 2021, by and between Aerpio Pharmaceuticals, Inc. and EyePoint Pharmaceuticals, Inc (Filed With SEC on August 23, 2021)

Subscription Agreement, dated May 16, 2021, by and among Aerpio Pharmaceuticals, Inc. and each purchaser identified on Exhibit A thereto (Filed With SEC on May 17, 2021)

Agreement and Plan of Merger, dated May 16, 2021, among Aerpio Pharmaceuticals, Inc., Aadi Bioscience, Inc. and Aspen Merger Subsidiary, Inc (Filed With SEC on May 17, 2021)

Consulting Services Agreement, entered into on April 1, 2021, by and between Aerpio Pharmaceuticals, Inc. and Kevin G. Peters (Filed With SEC on April 1, 2021)

Amendment to Transition Services Agreement, entered into on April 1, 2021, by and between Aerpio Pharmaceuticals, Inc. and Kevin G. Peters (Filed With SEC on April 1, 2021)

Transition Services Agreement, entered into on February 9, 2021, by and between Aerpio Pharmaceuticals, Inc. and Kevin Peters (Filed With SEC on February 16, 2021)

Amendment No. 2 to Employment Agreement, entered into on January 31, 2021, by and between Aerpio Pharmaceuticals, Inc. and Joseph Gardner (Filed With SEC on February 1, 2021)

Amendment No. 1 to License Agreement, dated May 11, 2020, by and between Aerpio Pharmaceuticals, Inc. and GB004, Inc (Filed With SEC on May 12, 2020)

Description of Registrants Securities (Filed With SEC on March 16, 2020)

Employment Agreement, dated November 6, 2019, by and between the Company and Regina Marek (Filed With SEC on November 7, 2019)

Offer Letter, dated July 15, 2018, by and between the Company and Gina Marek (Filed With SEC on October 18, 2019)

Underwriting Agreement, dated June 26, 2018, between the Company and Guggenheim Securities, LLC, as representative of the several underwriters party thereto (Filed With SEC on June 27, 2018)

License Agreement dated June 24, 2018, by and between Aerpio Pharmaceuticals, Inc. and Gossamer Bio, Inc (Filed With SEC on June 25, 2018)

Fourth Amendment to Office Lease and Assignment and Assumption of Lease, dated March 29, 2018, by and between Blue Ash Landings Acquisition, LLC and Aerpio Pharmaceuticals, Inc (Filed With SEC on April 2, 2018)

Senior Cash Incentive Bonus Plan of the Company (Filed With SEC on March 15, 2018)

Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on December 18, 2017)

Employment Agreement, effective as of November 15, 2017, by and between Aerpio Pharmaceuticals, Inc. and Michael Rogers (Filed With SEC on November 14, 2017)

First Amendment to Employment Agreement, dated October 8, 2017, by and between Aerpio Pharmaceuticals, Inc. and Joseph Gardner (Filed With SEC on October 10, 2017)

Employment Agreement, entered into on October 8, 2017, by and between Aerpio Pharmaceuticals, Inc. and Stephen Hoffman (Filed With SEC on October 10, 2017)

AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2017)

AERPIO PHARMACEUTICALS, INC. DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on March 17, 2017)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF AERPIOPHARMACEUTICALS, INC. (Filed With SEC on March 17, 2017)

AERPIO THERAPEUTICS, INC. 2011 EQUITY INCENTIVE PLAN ARTICLE I ESTABLISHMENTAND TERM (Filed With SEC on March 17, 2017)

AERPIO PHARMACEUTICALS, INC. 2017 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 17, 2017)

AERPIO PHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 17, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 17, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on March 17, 2017)

OFFICE LEASE (Filed With SEC on March 17, 2017)

AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 17, 2017)

AGREEMENTAND PLAN OF MERGER AND REORGANIZATION among ZETAACQUISITION CORP. II, a Delaware corporation AERPIOACQUISITION CORP., a Delaware corporation and AERPIOTHERAPEUTICS, INC.,... (Filed With SEC on March 13, 2017)

PROMISSORY NOTE (Filed With SEC on August 14, 2013)

Category

Industry

Companies

Contracts

Aerpio Pharmaceuticals, Inc. Contracts & Agreements